Dupont Capital Management Corp Veracyte, Inc. Transaction History

Dupont Capital Management Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	SELL	$15.31 - $29.94 $8,221 - $16,077	-537 Reduced 9.69%	5,006 $0
Q3 2022 Oct 31, 2022	SELL	$16.58 - $27.9 $36,011 - $60,598	-2,172 Reduced 28.15%	5,543 $92,000
Q1 2022 Apr 27, 2022	SELL	$21.94 - $42.51 $14,985 - $29,034	-683 Reduced 8.13%	7,715 $213,000
Q4 2021 Jan 31, 2022	SELL	$36.09 - $53.79 $120,865 - $180,142	-3,349 Reduced 28.51%	8,398 $346,000
Q3 2021 Nov 03, 2021	SELL	$35.62 - $52.97 $59,164 - $87,983	-1,661 Reduced 12.39%	11,747 $546,000
Q1 2021 Apr 29, 2021	SELL	$44.47 - $81.38 $122,292 - $223,795	-2,750 Reduced 17.02%	13,408 $721,000
Q4 2020 Jan 28, 2021	SELL	$32.49 - $61.88 $39,182 - $74,627	-1,206 Reduced 6.95%	16,158 $791,000
Q3 2020 Oct 29, 2020	SELL	$26.73 - $35.67 $31,086 - $41,484	-1,163 Reduced 6.28%	17,364 $564,000
Q2 2020 Jul 24, 2020	SELL	$19.49 - $28.11 $32,255 - $46,522	-1,655 Reduced 8.2%	18,527 $480,000
Q1 2020 Apr 29, 2020	SELL	$16.13 - $30.17 $795,144 - $1.49 Million	-49,296 Reduced 70.95%	20,182 $491,000
Q3 2019 Oct 28, 2019	SELL	$23.87 - $30.93 $7,328 - $9,495	-307 Reduced 0.44%	69,478 $1.67 Million
Q2 2019 Jul 30, 2019	BUY	$22.1 - $28.56 $159,429 - $206,031	7,214 Added 11.53%	69,785 $1.99 Million
Q4 2018 Feb 01, 2019	BUY	$9.15 - $14.85 $572,524 - $929,179	62,571 New	62,571 $787,000

316

81.8M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.23B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.